CATALYST BIOSCIENCES INC (CBIO) Stock Balance Sheet
NASDAQ:CBIO - Nasdaq - US14888D2080 - Common Stock - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.23M | 21.67M | 44.35M | 30.40M | 15.40M | |||
| Marketable Securities | N/A | 0.00 | 2.50M | 49.00M | 61.50M | |||
| Receivables | 1.20M | 5.00M | 1.82M | 3.30M | 15.00M | |||
| Other Current Assets | 1.70M | 1.54M | 2.81M | 6.80M | 4.20M | |||
| Total Current Assets | 5.13M | 28.21M | 51.48M | 89.50M | 96.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 70.00K | 3.71M | 2.30M | 2.20M | |||
| Investments And Advances | N/A | N/A | 0.00 | 2.50M | N/A | |||
| Other Non-Current Assets | 168.00K | 168.00K | 472.00K | 500.00K | 300.00K | |||
| Total Non-Current Assets | 4.83M | 238.00K | 4.19M | 5.30M | 2.50M | |||
| TOTAL ASSETS | 9.96M | 28.44M | 55.66M | 94.80M | 98.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.63M | 4.07M | 7.52M | 9.90M | 9.60M | |||
| Accounts Payable | 158.00K | 194.00K | 6.42M | 5.90M | 4.30M | |||
| Other Current Liabilities | 0.00 | 12.56M | 230.00K | 2.00M | 15.00M | |||
| Total Current Liabilities | 1.78M | 16.82M | 14.16M | 17.80M | 28.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.66M | 0.00 | 408.00K | 1.00M | 1.30M | |||
| Total Non-Current Liabilities | 4.66M | 0.00 | 408.00K | 1.00M | 1.30M | |||
| TOTAL LIABILITIES | 6.45M | 16.82M | 14.57M | 18.80M | 30.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -414.72M | -410.94M | -402.69M | -314.80M | -258.50M | |||
| Additional Paid In Capital | 384.89M | 389.21M | 443.75M | 390.80M | 326.80M | |||
| Common Shares | 33.35M | 33.35M | 31.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 37.98M | 37.76M | 31.41M | 22.10M | 12.00M | |||
| Tangible Book Value per Share | -0.78 | -0.57 | 1.31 | 3.44 | 5.69 | |||
| Total Shareholders' Equity | 3.52M | 11.62M | 41.09M | 76.10M | 68.30M | |||
| TOTAL LIABILITIES AND EQUITY | 9.96M | 28.44M | 55.66M | 94.80M | 98.60M | |||
| Statistics | ||||||||
| Current Ratio | 2.88 | 1.68 | 3.63 | 5.03 | 3.33 | |||
| Return On Assets (ROA) | -444.02% | -28.98% | -157.98% | -59.32% | -55.96% | |||
| Return On Equity (ROE) | -1257.95% | -70.93% | -214.01% | -73.90% | -80.79% | |||
All data in USD , ROIC based on taxRate of 0.21